PAGAN |
Date |
Start |
Duration |
Chairperson |
Presenter |
Topic |
PAGANZ |
8-Feb-11 |
12:30 |
1:00 |
Bruce Charles |
|
AGM |
PAGANZ |
|
13:30 |
|
|
PAGANZ |
|
Program for PAGANZ 2011 |
|
31-Jan-11 |
Final hardcopy version |
|
|
|
PAGANZ |
Date |
Start |
Duration |
Chairperson |
Presenter |
Topic |
PAGANZ |
8-Feb-11 |
12:30 |
1:00 |
Bruce Charles |
|
AGM |
Oral Presentations I |
|
|
|
|
|
|
PAGANZ |
|
13:30 |
0:20 |
Diane Mould |
Samara Gaonzik |
Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically-Ill Patients from a Multi-Center Study Provide Dosing Recommendations for Patients |
PAGANZ |
|
13:50 |
0:20 |
. |
Yoke-Lin Lo |
Population pharmacokinetics of midazolam in critically ill septic patients |
PAGANZ |
|
14:10 |
0:20 |
. |
Abhishek Gulati |
Identification and initial evaluation of a prototype clotting time test for enoxaparin |
PAGANZ |
|
14:30 |
0:20 |
. |
Daniel Wright |
The use of PKPD simulations to inform the rational use of medicines in clinical practice: the case of simvastatin circadian dosing |
PAGANZ |
|
14:50 |
0:20 |
. |
Lee Kien Foo |
Methods to Determine Optimal Sampling Windows for Nonlinear Mixed Effects Models |
15:10 |
0:30 |
|
Coffee + Posters |
|
|
|
PAGANZ |
|
15:40 |
0:20 |
Geoff Isbister |
Kris Jamsen |
Optimal designs for population pharmacokinetic studies of the partner drugs administered with artemisinin derivatives |
PAGANZ |
|
16:00 |
0:20 |
. |
Kiana Keyvanjah |
Development of a Mechanism-Based Model for the Pharmacodynamics of Daptomycin against Methicillin Resistant Staphylococcus aureus (MRSA). |
PAGANZ |
|
16:20 |
0:20 |
. |
Julia Korell |
Modelling red blood cell data |
PAGANZ |
|
16:40 |
0:20 |
. |
Marie Berglund |
Initial exploration of numerical methods for fitting models to PK data |
PAGANZ |
|
17:00 |
|
|
Close |
|
PAGANZ |
|
18:00 |
|
|
Social Evening Greys Room, Langham Hotel |
|
22:00 |
|
|
Leave Greys Room |
|
|
|
PAGANZ |
Date |
Start |
Duration |
Chairperson |
Presenter |
Topic |
9-Feb-11 |
8:00 |
0:30 |
|
Breakfast |
|
|
PAGANZ |
|
8:30 |
0:15 |
|
Khaled Al-Faify |
Population Pharmacokinetics of Gentamicin in Saudi Newborns during the 1st Week of Life |
PAGANZ |
|
8:45 |
0:15 |
. |
Yookhwan Noh |
Population pharmacokinetic and pharmacodynamics analysis of lipid emulsion propofol in pediatric patients |
PAGANZ |
|
9:00 |
0:15 |
. |
Shu Chin Ma |
Quantifying Disease Progress with Inactive Treatments in Multiple Parkinson’s Disease Trials |
PAGANZ |
|
9:15 |
0:15 |
. |
Eun-Kyung Lee |
fit4NM : A tool for NONMEM users |
PAGANZ |
|
9:30 |
0:15 |
. |
Sam Holford |
Antibiotic Dosing Calculator in Neonates and Children Trial |
PAGANZ |
|
9:45 |
0:15 |
. |
Pavan Kumar |
Generalisation of T-optimality for discriminating between competing models – an application to paracetamol overdose |
PAGANZ |
|
9:55 |
0:10 |
. |
Kate Owens |
The effect of surgery on the glucuronidation and sulphation of paracetamol |
10:00 |
0:30 |
|
Tea Break |
|
|
|
What can Pharmacometricians and Statisticians learn from each other? |
|
|
|
|
|
|
PAGANZ |
|
10:30 |
0:30 |
David Foster |
Stephen Senn |
Statisticians and Pharmacometricians: What can they learn from each other? |
PAGANZ |
|
11:00 |
0:30 |
. |
Diane Mould |
Population Pharmacokinetic-Pharmacodynamic Modeling: When Modeling Meets Reality |
PAGANZ |
|
11:30 |
0:30 |
. |
Richard Upton |
Meta-Modelling |
12:00 |
1:30 |
|
Lunch |
|
|
|
What do we need to learn to get the dose right for children? |
|
|
|
|
|
|
PAGANZ |
|
13:30 |
0:40 |
Carl Kirkpatrick |
Brian Anderson, Sam Holford |
What is needed for a dosing calculator? |
PAGANZ |
|
14:10 |
0:20 |
. |
Nick Holford |
Is Morphine Clearance Predictable in Humans? |
PAGANZ |
|
14:30 |
0:15 |
. |
Amanda Potts |
Dexmedetomidine Hemodynamics in Children after Cardiac Surgery |
PAGANZ |
|
14:45 |
0:15 |
. |
Anita Sumpter |
Predicting Weight Using Postmenstrual Age – Neonates to Adults |
15:00 |
0:30 |
|
Coffee |
|
|
|
Oral Presentations II |
|
|
|
|
|
|
PAGANZ |
|
15:30 |
0:20 |
. |
Lagishetty Chakradhar |
Design of pharmacokinetic studies for latent covariates |
PAGANZ |
|
15:50 |
0:20 |
. |
Kashyap Patel |
Development of fluconazole dosage guidelines in critically ill patients receiving continuous venovenous hemodiafiltration |
PAGANZ |
|
16:10 |
0:20 |
. |
Wojciech Krzyzanski |
Modeling of non-stationary RBC survival: Effect of erythropoietin on RBC mortality vs. production in rats. |
PAGANZ |
|
16:30 |
0:20 |
. |
Joel Iedema |
Population Pharmacokinetics of Paracetamol in Overdose in a Single Patient |
PAGANZ |
|
16:50 |
0:20 |
. |
Carolyn Coulter |
Utilising prior literature population models to inform clinical practice – a dosing regimen for immediate N-acetyl cysteine treatment of paracetamol overdose |
17:00 |
|
|
|
|
|
|